NCT01970397 - JUVEDERM® Ultra XC vs. Belotero Balance® for Perioral Lines | Biotech Hunter

Enrollment

138

Participants

Timeline

Start Date

October 21, 2013

Primary Completion Date

August 4, 2014

Study Completion Date

August 4, 2014

Conditions

Patients With Moderate to Severe Perioral Lines

Interventions

DEVICE

JUVEDERM® Ultra XC

Up to 3.0 mLs JUVEDERM® Ultra XC injected into the mid to deep dermis (2.0 mLs for initial treatment and 1.0 mL for touch-up treatment).

DEVICE

Belotero Balance®

Up to 3.0 mLs Belotero Balance® injected into the mid to deep dermis (2.0 mLs for initial treatment and 1.0 mL for touch-up treatment).

Trial Locations (1)

Chapel Hill